2009•Journal of medical imagingRequires access

Transcatheter hepatic arterial chemoembolization combined percutaneous ethanol injection in treating primary hepatic carcinoma

Xiaogang Hu

Abstract

Objective:To evaluate clinical efficacy of the transcatheter hepatic arterial chemoembolization (TACE)combined percutaneous ethanol injection(PEI)in treating primary hepatic carcinoma. Methods:85 cases with primary hepatic carcinoma were divided into TACE+PEI group and TACE group. 21 cases underwent TACE combined PEI treatment, 64 cases underwent TACE treatment.Results:The effective rate of TACE+PEI group is 85.71%, the one of TACE group is 68.75%. The 1year, 2 year, 3 year survival rates of the TACE+PEI group and TACE group were 97.2%, 72.1%, 39.6% and 83.6%, 34.3%, 16.2% respectively.Conclusion:TACE combined PEI is a better treatment of primary hepatic carcinoma.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Percutaneous ethanol injection, Transcatheter arterial chemoembolization, Hepatocellular carcinoma, Percutaneous, Hepatic carcinoma, Gastroenterology, Internal medicine